Schibli, Roger, Prof. Dr.

Prof. Dr.  Roger Schibli

Prof. Dr. Roger Schibli

Inst. f. Pharmazeutische Wiss. 

HCI  H 431 

Vladimir-Prelog-Weg 1-5/10

8093 Zürich


  • phone +41 44 633 74 64 
  • fax +41 44 633 13 67 
  • phone (Alt.) +41 56 310 28 37 
  • phone (Sec.) +41 44 633 74 92 
  • mail
  • vcard V-Card (vcf, 1kb)

Additional information

Curriculum Vitae

Prof. Roger Schibli is an Associate Professor in the Department of Chemistry and Applied Biosciences (ETH Zurich) since 2010, and Head of the Center for Radiopharmaceutical Science (CRS), a joint endeavor between the ETH Zurich, the Paul Scherrer Institute and the University Hospital Zurich. Prof. Schibli studied Chemistry at the University of Basel, Switzerland and performed his doctoral thesis under the supervision of Prof. Thomas Kaden. After his graduation, he spent two years at the University of Missouri-Columbia, MO as a post-doctoral fellow. He was appointed Assistant Professor (tenure track) for Therapeutics Technologies at the Institute of Pharmaceutical Sciences (ETH Zurich) in 2004 and was tenured in 2009.

Prof. Schibli's research interestscover targeted tumor diagnosis and therapy using radiolabeled compounds. Apart from the chemical modification and radioactive labeling of molecules, his group emphasizes on the biological and pharmacological characterization and optimization of the radioactive compounds including non-invasive PET and SPET imaging. New, medically relevant radionuclides for his pre-clinical and clinical studies are produced at the cyclotron and neutron facilities of the ETH and the Paul Scherrer Institute.

Page URL:
Fri Jun 23 22:50:53 CEST 2017
© 2017 Eidgenössische Technische Hochschule Zürich